MD @MaastrichtUMC & PhD candidate @CARIMMaastricht studying #DVT resolution to prevent #PostThromboticSyndrome.
Joined March 2018
- Tweets273
- Following420
- Followers353
- Likes2.2K
Pinned Tweet
New publication 🚨 @BloodAdvances
We explore if fibrin clot properties could be used to select patients with iliofemoral DVT for CDT:
- Properties associated with 1-year patency
- PTS was 5x ⬇️ by CDT only in patients with high baseline fibrinogen levels ~ tinyurl.com/4cxprw5u
Aaron Iding retweeted
📢 Practice-changing data from the Adjust-DVT study!
✅ Age-adjusted D-dimer safely rules out DVT in low/non-high pretest probability patients
📉 Reduces unnecessary ultrasounds
🔍 +17% yield in patients ≥75 years
#ISTH2025 #DVT #Thrombosis #LessIsMore
Aaron Iding retweeted
🌍 Big ideas start early. Leadership does too. The ISTH SSC is where innovation meets mentorship—and Early Career Co-Chairs are at the heart of it. In our latest article, we spotlight four rising leaders who are already shaping the future of the field: bit.ly/3XOmNCI
Aaron Iding retweeted
So inspiring to see the #ISTHearlycareer leaders play important roles to advance many @isth program.
Learn more about ISTH #SSC Co-Chairs and their important contributions:
➡️@gael_beverley
➡️@dino_mehic
➡️@Aaron_Iding
➡️Cheryl Maier
👥 Meet the future of thrombosis and hemostasis research. In "Leading from the Start", we highlight the pivotal role of the ISTH SSC and its Early Career Co-Chairs—emerging leaders who are already making a global impact.
Read more here: bit.ly/3XOmNCI
Aaron Iding retweeted
👥 Meet the future of thrombosis and hemostasis research. In "Leading from the Start", we highlight the pivotal role of the ISTH SSC and its Early Career Co-Chairs—emerging leaders who are already making a global impact.
Read more here: bit.ly/3XOmNCI
Aaron Iding retweeted
Post-hoc analysis of the Hokusai VTE Cancer trial showed that treatment for recurrent VTE on AC were heterogeneous, and there were high risks of second recurrent VTE (9%) and major bleeding (10%) within 3 months!
doi.org/10.1016/j.jtha.2025.…
@JTHjournal @GaryRaskob @MarcCarrier1
Aaron Iding retweeted
🥳 Thrilled to share our new study about post-thrombotic vascular sequelae
💡After PE, low CD34⁺ cell levels at RPVO assessment suggest a decreased regenerative potential contributing to perfusion defects @INNOVTE1
⤵️
🩸 Thrombose & embolie pulmonaire : Bravo @GendronNico : les CD34⁺ pourraient prédire les séquelles post-EP. Un pas de plus vers une meilleure compréhension de la recanalisation du thrombus ! @parcc_inserm
📄 [DOI: 10.1007/s12015-025-10865-0](doi.org/10.1007/s12015-025-1…)
Aaron Iding retweeted
Exited to share our paper on biological aging in #hemophilia, an inherited bleeding disorder with significant improvements in life expectancy over the last decades.
Our results indicate an accelerated biological aging in people with hemophilia.
➡️ doi.org/10.3324/haematol.202…
Aaron Iding retweeted
As we prepare for the #ISTH2025 Congress in Washington, D.C., we are reminded of the strength of our global community. The ISTH remains firmly dedicated to advancing science, supporting research and fostering innovation across borders. Read more: isth.org/news/695029/Message…
Aaron Iding retweeted
Interested in the fundamentals of key topics in #thrombosis and #hemoastasis?
Don't miss the BRAND NEW Educational Review Series in @isth @JTHjournal
Check it out 👇
Big news from @JTHjournal: a NEW Educational Review Series designed to break down the fundamentals of key topics in thrombosis & hemostasis!🔬
These reviews are must-read resources for clinicians, researchers & healthcare professionals. Learn more here: bit.ly/3EAaVNZ
Aaron Iding retweeted
Attention all @ISTH members!
This is your opportunity to shape the future of the ISTH and the field of #thrombosis and #hemostasis by serving as a volunteer on an ISTH committee!
Deadline for applications is March 3!
To learn more and apply see 👇
Want to make a impact in the thrombosis and hemostasis community? Here’s your chance! We are looking for passionate members to serve on a committee! As a volunteer, you’ll help shape the Society’s future, collaborate with global experts, grow your professional network, and develop leadership skills.
Ready to get involved? Apply today: bit.ly/4jH9xsV
Aaron Iding retweeted
Attention all @ISTH members located in North America! This is your opportunity to shape the field of #thrombosis and #hemostasis:
Apply now for the position of 2027 Annual Congress Planning Committee Chair.
Deadline is March 14. To learn more and apply see link 👇
Lead the Future of the ISTH Congress⭐! We are seeking a visionary leader to serve as the 2027 Annual Congress Planning Committee Chair!
If you’re an active ISTH member with a passion for advancing the field, we invite you to apply: bit.ly/3CvMnoB
Aaron Iding retweeted
Did you know? Around 50% of patients with acute CAT in your practice do not meet the inclusion criteria of the RCTs. Listen to the podcast with @GBarnesMD about recent trials taking a more pragmatic approach. @Medthority
medthority.com/medical-educa…
Aaron Iding retweeted
Honored, thrilled, thankful for the opportunity — 🔥#thromboinflammation (NLRP3/IL-1) & #VTE 🩸— such an exciting field harbouring transformative discoveries and soon therapeutic advances🌟
🎥 soon available at: canvector.ca
Thank you @canvector @JRand083 ++
Join us today at 11am ET for the next edition of our National Thrombosis Seminar series as we discuss "The NLRP3 Inflammasome and Interleukin-1 in Thromboinflammation and #VTE"
Featuring: @NicolaPotereMD
Register: buff.ly/4g04UHl
#Thrombosis #Research
Aaron Iding retweeted
A recent Swedish nationwide study reveals that venous thromboembolism (VTE) is linked with a small but notable percentage of out-of-hospital cardiac arrests (OHCA), particularly affecting younger women. The research emphasizes the critical need for improved preventive measures and early detection to tackle the high fatality rates associated with VTE-related OHCA.
Read more about this study: jthjournal.org/article/S1538…
Aaron Iding retweeted
📍New editorial from the @isth Early Career Committee highlighting the importance of interdisciplinary collaboration and its opportunities within the thrombosis and hemostasis field. 🔖
#ISTHEarlyCareer
@SarahSewar @kohli_shrey @beckyzon @Aaron_Iding @NicolaPotereMD
@Plateletpaul @gauer_s @joythitac @PoolePAR_ty @renee_eslick @zara_sayar
📣📣The ECC's latest editorial is out!
Hope you enjoy reading it as much as we enjoyed writing it
Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their niche -Journal of Thrombosis and Haemostasis jthjournal.org/article/S1538…
Aaron Iding retweeted
📣📣The ECC's latest editorial is out!
Hope you enjoy reading it as much as we enjoyed writing it
Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their niche -Journal of Thrombosis and Haemostasis jthjournal.org/article/S1538…
Aaron Iding retweeted
📢 The countdown is on! The #ISTH2025 abstract submission portal opens Nov 29. Ready to showcase your research on the global stage? Join us for an incredible Congress—submit your work and be part of the conversation driving advancements in thrombosis and hemostasis!
Abstract guidelines are now available at isth2025.org/abstracts
Aaron Iding retweeted
Science! Have you read the #PEERLESS trial comparing
#thrombectomy (#LBMT) with #catheter-directed #thrombolysis (#CTD) for Intermediate-risk #pulmonary #embolism (#PE)? A critical read and analysis: 🧵1/5 ahajournals.org/doi/10.1161/…
Aaron Iding retweeted
Don't miss the upcoming @ISTH #EarlyCareer career development webinar on October 22 at 13:00 UTC
on
➡️research careers outside of academia
w/Amalie Carnbring Deemand, Patrick Fogarty, moderated by @gauer_s
bit.ly/3zdeHdW
Aaron Iding retweeted
Vandaag 13 oktober de 11e Wereld Trombosedag! CARIM & MUMC+ op locatie bij Vitala+ geriatrische revalidatiezorg in Maastricht. Inzicht in trombose en behandeling door clinici Winckers en Aarts, veel vragen, vlaai en koffie odz: “Stop de prop”. @Trombosestng @MaastrichtUMC
